Denver-based PCM Trials, the largest independent mobile research nurse visit provider for decentralized clinical trials (DCTs), announces the acquisition of EmVenio Research based in Durham, North Carolina. EmVenio is the largest provider of community-based clinical trial sites served with mobile research units. The acquisition strengthens PCM Trials’ and EmVenio’s abilities to recruit and retain diverse populations for clinical research studies, as required for regulatory approval. Site networks are key to delivering critical study data for sponsors; by combining capabilities with EmVenio, PCM Trials now has access to a site network that is focused on serving underrepresented patient populations in previously hard-to-reach communities and can work flexibly with sponsors to achieve their study goals.
Read the full article: PCM Trials Acquires EmVenio Research to Create the Most Patient-Centric Model for Hybrid and Decentralized Clinical Trials //
Source: https://www.prnewswire.com/news-releases/pcm-trials-acquires-emvenio-research-to-create-the-most-patient-centric-model-for-hybrid-and-decentralized-clinical-trials-302070059.html